Evotec and Plectonic Advance T-Cell Engagers for Solid Tumors
Hamburg, Germany, and Sydney, Australia, September 2, 2026 Evotec SE and Plectonic Biotech have entered into a research collaboration...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Hamburg, Germany, and Sydney, Australia, September 2, 2026 Evotec SE and Plectonic Biotech have entered into a research collaboration...
Irvine, California, USA, September 1, 2026 SkinMedica, part of Allergan Aesthetics, an AbbVie company, has expanded its regenerative skincare...
Needham, Massachusetts, USA,August 20, 2026 Evolved By Nature, Inc. announced that its programmable peptide platform has been used in...
